Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Private label firm names Mark Olesnavage exec VP and chief operating officer for OTC drug operations. Most recently VP-sales and marketing, Olesnavage takes on additional responsibility for R&D, quality control and human resources and will continue to oversee the development of "new products to maximize on the many" Rx-to-OTC switch opportunities, Perrigo said July 19.